Mark Wagner Joins Minnetronix Board of Directors
Minnetronix, a leading medical technology and innovation company, today announced that Mark Wagner has joined the company’s board of directors, according to a Business Wire press release.
Wagner has more than 30 years of experience in the medical device industry, most recently serving as president and CEO of Minnesota based Celleration, Inc., until its acquisition by Alliqua in May 2015. He continues to serve on Alliqua’s board of directors.
Prior to Celleration, Wagner co-founded and served as board chairman for Orasi Medical, a University of Minnesota spinout developing diagnostic tools for neurological diseases.
